ResMed's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
ResMed (NYSE:RMD) is scheduled to release its quarterly earnings report on January 24, 2024. Analysts predict an EPS of $1.79. Investors are looking for an earnings beat and positive guidance for future growth. ResMed's stock performance has been negative over the past year, with shares down 23.84%. Historical data shows mixed reactions to past earnings reports, with both increases and decreases in share price following announcements.
January 23, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
ResMed is expected to report an EPS of $1.79 in its upcoming earnings release. Historical performance shows varied reactions to earnings reports, with the stock price sometimes dropping despite an earnings beat. Long-term shareholders may be bearish due to the 23.84% decline in share price over the last year.
The short-term impact on RMD's stock price is uncertain due to mixed historical reactions to earnings reports. While an earnings beat could positively influence the stock, the negative long-term performance and previous post-earnings drops in price suggest a cautious outlook. The score is neutral, reflecting this uncertainty.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100